Clinical trial
A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and…
NCT00156403 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00156403 |
|---|---|
| Title | A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis |
| Official title | Hereditary Pancreatitis Amlodipine Trial(H-PAT): A Pilot Study |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatitis |
| Intervention type | Drug |
| Interventions | amlodipine (drug) |
| Enrollment | 8 |
| Start date | Aug 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: